openPR Logo
Press release

Blood Cancer Drugs Market Trend to 2025 Profiling Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer Inc., Eli Lily & Co., AstraZeneca, AbbVie Inc.

09-17-2018 11:12 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Blood Cancer Drugs Market Trend to 2025 Profiling Johnson &

The demand for blood cancer drug is primarily driven by growing death incidences by blood cancer, and continuous innovation for developing novel treatments with the help of several ongoing clinical trials. Moreover, increasing research and development of biological and targeted therapies as treatment will spur the blood cancer drugs market during the upcoming period. However, the high price of drugs and the stringent government policies will limit the growth of blood cancer drugs market during the forecast period.

The global blood cancer drugs market is valued at USD 24.3 billion in 2017 and is anticipated to grow at a CAGR of 11.1% during the forecast period.

Sample copy of this report@ https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-free-sample

Top Key Player:-

Johnson & Johnson Inc.
Amgen Inc.
Bayer AG.
Pfizer, Inc.
AbbVie Inc.
Roche Holding AG.
Celgene Corporation
AstraZeneca, Novartis AG
GlaxoSmithKline PLC
Merck & Co., Inc.
Eli Lily & Co.

Most of the blood cancers start in the bone marrow, where blood is produced. In blood cancer the growth of normal blood cells is dislodged by the uncontrollable growth of abnormal blood cells. These cancerous cells prevent the blood from performing many of its functions. Hence, the existing treatments of blood cancer are being the foundation for developing the new drugs. The steady flow of the blood cancer drugs has created opportunity for research and development in the existing market. For instance, Amgen Inc. received approval for BLINCYTO in July 2017, which is used in treating B-cell precursor Acute Lymphoblastic leukemia. Similarly, European blood cancer drugs market witnessed the approvals of Gazyvaro, by Roche AG that is used in treating advanced follicular lymphoma. Also, novel technologies like CAR-T are likely to be launched this year.

The global blood cancer drugs market is segmented into blood cancer type, drugs and treatment approaches. On the basis of blood cancer type, the global blood cancer drugs market is segmented into leukemia, lymphoma and myeloma. The lymphoma segment is expected to drive the majority market of blood cancer drugs followed by leukemia. The global market of this segment is primarily driven by the increasing prevalence of lymphoma, and presence of effective treatments in the market. On the basis of drugs, the global blood cancer drugs market is further categorized into Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others. This continuous innovation for treating various sub-types of blood cancers has led to the development of novel types of treatments. For instance, the combination of Revlimid and Velcade has emerged as the preferential drugs in trials for treating multiple myeloma.

Browse Complete Report Summary @ https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/

On the basis of treatment approaches the global blood cancer drugs market is further segmented into Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic. Due to availability of variety of chemotherapeutic agent in the market chemotherapeutic drugs are expected to hold the higher share in blood cancer drugs market. Moreover, their effectiveness for the treatment of blood cancer and increasing number of cancer patients globally has garnered more demand for chemotherapeutic drugs throughout the world.

Geographically, the global blood cancer drugs market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the blood cancer drugs market which is followed by Europe and Asia Pacific. Favorable reimbursement policies, surge in R&D investments of various companies, as well as the increase in the number of blood cancer treatments are some of the major factors responsible for the growth of North Americaโ€™s blood cancer drugs market. Moreover, Asia-Pacific region has been identified as the lucrative market for the for blood cancer drugs due to increasing awareness of the use of these drugs, increased healthcare expenditure, and rising per capita disposable income. These are some of the major factors which are influencing the growth of the blood cancer drugs in Asia-pacific region.

Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/inquire-before-buying

Key Findings from the study suggest blood cancer drugs in the market are much innovative and manufacturers are progressively concentrating on innovation of combination drugs. Companies are in a stage of development of new drugs in order to provide novel treatments for blood cancer. The immunotherapy segment is anticipated to grow at a high growth rate over the forecast period. The growth of this segment is primarily driven by increased awareness for its use as an alternative and effective treatment for blood cancer. North America is presumed to dominate the global blood cancer drugs market over the forecast period. Asia Pacific region which shows signs of high growth potential owing to the booming economies of India, and China.

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blood Cancer Drugs Market Trend to 2025 Profiling Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer Inc., Eli Lily & Co., AstraZeneca, AbbVie Inc. here

News-ID: 1241846 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Decision Intelligence Market Forecasts Impressive Growth, Set to Reach USD 36.66 Billion by 2032 with a CAGR of 15.4%
Decision Intelligence Market Forecasts Impressive Growth, Set to Reach USD 36.66 โ€ฆ
The recently published Decision Intelligence Market study report by Polaris Market Research reveals that the global market was USD 10.52 billion in 2023, with a CAGR of 15.4% projected from 2024 to 2032. The global market is expected to offer an absolute opportunity of USD 36.66 billion by 2032. ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/decision-intelligence-market/request-for-sample Decision intelligence is a contemporary recently surfacing regulation that targets enhancing decision-making procedures within firms coveringโ€ฆ
Car Camera Cleaning Systems Market Projected to Hit US$ 4,401.80 Million at a 24.5% CAGR by 2032 | PMR
Car Camera Cleaning Systems Market Projected to Hit US$ 4,401.80 Million at a 24 โ€ฆ
The recently published Car Camera Cleaning Systems Market study report by Polaris Market Research reveals that the global market was USD 508.84 Million in 2022, with a CAGR of 24.5% projected from 2023 to 2032. The global market is expected to offer an absolute opportunity of USD 4,401.80 Million by 2032. ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/car-camera-cleaning-systems-market/request-for-sample The notable surge in concentration on road security and consistently proliferating expansion of progressive vehicleโ€ฆ
Ultrasound Probe Cover Market Predicted to Grow at 6.06% CAGR, Reaching USD 378.50 Million by 2032 | PMR
Ultrasound Probe Cover Market Predicted to Grow at 6.06% CAGR, Reaching USD 378. โ€ฆ
๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฎ๐ฅ๐ญ๐ซ๐š๐ฌ๐จ๐ฎ๐ง๐ ๐ฉ๐ซ๐จ๐›๐ž ๐œ๐จ๐ฏ๐ž๐ซ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ๐Ÿ๐Ÿ“.๐ŸŽ๐ŸŽ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ‘๐Ÿ•๐Ÿ–.๐Ÿ“๐ŸŽ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ”.๐ŸŽ๐Ÿ”% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐. Ultrasound probe covers are an essential component of an ultrasound users' toolkit. These products ensure the safety of patients during exams and help keep the ultrasound probe clean. Ultrasound probe coversโ€ฆ
Orthopedic Devices Market Predicted to Reach USD 57.76 Billion by 2032, with a Notable Annual Growth Rate of 4.47% | Data by PMR
Orthopedic Devices Market Predicted to Reach USD 57.76 Billion by 2032, with a N โ€ฆ
๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐จ๐ซ๐ญ๐ก๐จ๐ฉ๐ž๐๐ข๐œ ๐๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ‘๐Ÿ–.๐Ÿ—๐Ÿ• ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ“๐Ÿ•.๐Ÿ•๐Ÿ” ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’.๐Ÿ’๐Ÿ•% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐. Osteoarthritis, rheumatoid arthritis, osteoporotic fractures, and carpal tunnel syndrome are just a handful of orthopedic illnesses and maladies that are growingly being cured clinically with orthopedic devices. The growing acceptance of these treatmentsโ€ฆ

All 5 Releases


More Releases for Johnson

Urgent Care Apps Market 2019 Analysis by Johnson & Johnson (Johnson & Johnson He โ€ฆ
"the Global Urgent Care Apps market is accounted for $312.93 million in 2017 and is expected to reach $6,382.75 million by 2026 growing at a CAGR of 39.8%. Growing demand owing to growing focus on patient-centric healthcare delivery and increase in penetration of 3G and 4G networks are some key factors influencing the market growth. However, poor internet connectivity in developing countries is restricting the growth of the market. Inโ€ฆ
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled โ€œGlobal Erythropoietin Market 2019 Research Report, 2015 โ€“ 2025โ€ offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitiveโ€ฆ
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumersโ€ฆ
Wet Tissues Market 2017- Johnson & Johnson, SC Johnson, Clorox, Beiersdorf, 3M
Apex Research, recently published a detailed market research study focused on the "Wet Tissues Market" across the global, regional and country level. The report provides 360ยฐ analysis of "Wet Tissues Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wet Tissues industry, and estimates the future trend of Wet Tissues market onโ€ฆ
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360ยฐ analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of thisโ€ฆ
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso โ€ฆ
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Salesโ€ฆ